BioMedix Vascular Solutions, Inc. – Trademark Portfolio
Entity Type: 03
BioMedix Vascular Solutions, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include PADNET and BIOMEDIX. The owner is based in St. Paul, MN.
178 E 9th Street
St. Paul, MN 55101
Showing of trademarks Trademarks
Trademark Classifications
BioMedix Vascular Solutions, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does BioMedix Vascular Solutions, Inc. have?
BioMedix Vascular Solutions, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.
What trademark classes does BioMedix Vascular Solutions, Inc. file in?
BioMedix Vascular Solutions, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 42 covers scientific and technological services; industrial analysis and research services.
What are BioMedix Vascular Solutions, Inc.'s most well-known trademarks?
BioMedix Vascular Solutions, Inc.'s registered trademark portfolio includes well-known marks such as PADNET and BIOMEDIX. These are among 2 currently registered trademarks in the portfolio.
What is BioMedix Vascular Solutions, Inc.'s trademark registration success rate?
BioMedix Vascular Solutions, Inc. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.